Fundraising Fox
Meddenovo
Lyon, FR · Founded 2023 · 10 employees on LinkedIn · 1 known investors
Find your way into Meddenovo
Each arrow is one introduction. Sign up to fill in the first one.
Ask Erhan Kılıçözlü to introduce you to Ilke Ugur Marion
You →Erhan · together at Meddenovo →Ilke
Sign up to find every way you can get introduced to Meddenovo
- Your email: who you already know at Meddenovo, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Meddenovo team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Meddenovo develops Mexa, an AI-powered platform for de novo design of cyclic peptide drug candidates. The company serves pharmaceutical partners seeking to discover novel peptide therapeutics for oncology, radiopharmaceuticals, and metabolic diseases.
Founders & leadership
Meddenovo was founded in 2023 by Ilke Ugur Marion.
Investors · 1
How we know: funding news · tech.eu · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountPre-seedJul 2024
ACT Venture Partners (lead)
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Meddenovo do?
- Meddenovo develops Mexa, an AI-powered platform for de novo design of cyclic peptide drug candidates. The company serves pharmaceutical partners seeking to discover novel peptide therapeutics for oncology, radiopharmaceuticals, and metabolic diseases.
- Who founded Meddenovo?
- Meddenovo was founded by Ilke Ugur Marion in 2023.
- Who are Meddenovo's investors?
- Meddenovo's investors include ACT Venture Partners.
- Where is Meddenovo headquartered?
- Meddenovo is headquartered in Lyon, FR.